Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes.
about
Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathiesThe role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis.Favorable outcome of juvenile dermatomyositis treated without systemic corticosteroids.The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis.High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort.Autoimmune neuromuscular disorders in childhoodVascular and connective tissue diseases in the paediatric world.Treatment approaches to juvenile dermatomyositis.The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression.Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional studyClinical analysis of 50 children with juvenile dermatomyositis.Management of cutaneous dermatomyositis.Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases.Clinical features and disease course of patients with juvenile dermatomyositis.Clinical course and outcomes of Iranian children with juvenile dermatomyositis and polymyositis.A Practical Approach to Juvenile Dermatomyositis and Juvenile Scleroderma.Treatment of Juvenile Dermatomyositis: An Update.Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome.Juvenile dermatomyositis: a tertiary center experience.Cardiac findings in children with juvenile Dermatomyositis at disease presentation.HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA).Juvenile dermatomyositis in a 4-year-old Kenyan girl.Disease patterns of juvenile dermatomyositis from Western India.Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research.Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult Dermatomyositis.Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: An international multicenter PRINTO study
P2860
Q26830775-7182F79B-E217-43FF-A935-DA0B718F3B99Q33694683-F92FDB75-AB6C-4E95-A61C-CFCC833676C5Q34124740-3C5DBAE0-D6B9-48CA-A146-32743C908B82Q34242363-DBDB1AC5-3DD7-4610-B51B-D62F93B65351Q35225827-B8509662-1E8B-4255-8ADD-715DBCA4C7C5Q35512273-6391D09F-CA1A-41DD-A306-0AD68A7693E8Q35680229-5CDB46E5-CCB8-4FB6-A012-052BC872FF9AQ35814405-D993244C-9E45-40D0-BACE-5B621BDF467FQ36086954-59AA241E-39E2-4F07-977E-E54DF0DE3CF6Q37240498-54C227B7-56A7-49CB-98B9-E5237E472B45Q37427265-295D6A91-DD6B-42E2-8E9D-C7BAC7114961Q37480302-D1A06528-2DB0-4404-BA5D-A3BFCE395E20Q37497903-A6557944-134E-4724-88AF-DBD22D729929Q38004835-C57F54AC-A868-4092-A82E-CE3F4021B318Q38022271-0B188E27-90A5-4081-A1E6-9573FB2A3E2FQ38131966-DFF46EE4-65EC-486E-9F3D-7FEC6C6C4D45Q38155955-57FB58E9-68B5-4EEE-8591-B706DEB99C4BQ38216182-F3A1A95B-4997-4D53-912B-CDC7EFA88312Q38613322-60A184FD-98AC-48CA-8C11-8CF1C75B7262Q38678257-08863CBE-CB9A-4ECE-A298-138CD8F30C21Q38786091-5A97076C-E011-404C-A476-158285CD0B80Q39036962-14875CA3-6CFE-46A9-A190-A0A0DDE2B8B8Q39426129-49DAFE5D-ECE3-4671-96F2-E594A8951582Q40154248-CFD5FEB6-89E3-496D-9F7F-CA60F963675EQ41694469-9A248DAB-CB74-41E2-BFC7-C462CC25EE3EQ41896241-F3B6A0CF-9875-4B24-9AEB-C4B4572A2F51Q45823613-7C106502-BB5F-47BF-A553-4D17D7D6A5FEQ47689325-6EAD2A25-94B8-4515-88D3-9FFC5C261F87Q50224678-9B21AD89-C089-47B7-A685-E53322C51145Q56966414-97107297-7586-4D61-ACF1-47E04D93B53C
P2860
Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical features and outcomes ...... hood onset myositis syndromes.
@ast
Clinical features and outcomes ...... hood onset myositis syndromes.
@en
type
label
Clinical features and outcomes ...... hood onset myositis syndromes.
@ast
Clinical features and outcomes ...... hood onset myositis syndromes.
@en
prefLabel
Clinical features and outcomes ...... hood onset myositis syndromes.
@ast
Clinical features and outcomes ...... hood onset myositis syndromes.
@en
P1476
Clinical features and outcomes ...... hood onset myositis syndromes.
@en
P2093
A V Ramanan
Brian M Feldman
P304
P356
10.1016/S0889-857X(02)00024-8
P577
2002-11-01T00:00:00Z